What assets does ARC hold following the sale of its operating companies?
The Company sold the 2,120,000 StemCells, Inc. shares that it held for resale for a total of $3.619m at an average of $1.707 per share (before broker commissions). ARC used part of this to pay off significant debts that had been incurred prior to and during the sale of the operating companies. The Company could also receive up to 530,000 shares from the escrow holding, subject to any claims made by StemCells, Inc. for any unforeseen liabilities.
